Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc vs Lopinavir/Ritonavir for HIV Post-Exposure Prophylaxis
NCT01533272Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Feb 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Hospital Clínic de Barcelona. Started Feb 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01533272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533272.